OTCMKTS:RGIN

Regenicin (RGIN) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
4,375 shs
Market Capitalization
$830,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
RGIN stock logo

About Regenicin Stock (OTCMKTS:RGIN)

Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.

RGIN Stock News Headlines

Tech GIANT’s Plans to Revolutionize Crypto…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
History of Walmart: Timeline and Facts
Regions Financial
Tech GIANT’s Plans to Revolutionize Crypto…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Tundra regions of the world
Regions Hospital
RGIN Pre-Market Quotes
See More Headlines
Receive RGIN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Regenicin and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/19/2020
Today
5/08/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
OTCMKTS:RGIN
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.04) per share

Miscellaneous

Free Float
N/A
Market Cap
$830,000.00
Optionable
Not Optionable
Beta
-17.47
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Randall E. McCoy (Age 75)
    Chairman, CEO & President
    Comp: $250k
  • Mr. John J. Weber (Age 74)
    CFO & Director
    Comp: $125k
  • Dr. J. Roy Nelson Ph.D. (Age 76)
    Controller & Chief Science Officer
    Comp: $150k

RGIN Stock Analysis - Frequently Asked Questions

How were Regenicin's earnings last quarter?

Regenicin, Inc. (OTCMKTS:RGIN) announced its quarterly earnings data on Wednesday, August, 19th. The company reported $0.00 earnings per share for the quarter.

What other stocks do shareholders of Regenicin own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Regenicin investors own include Energous (WATT), Vital Therapies (VTL), Xerox (XRX), Allergan (AGN), Leafbuyer Technologies (LBUY), (ZINCQ) (ZINCQ), Ambarella (AMBA) and Alstom (ALO).

How do I buy shares of Regenicin?

Shares of RGIN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:RGIN) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners